AHA Coding Clinic® for HCPCS - 2018 Issue 2; For Your Information

Changes to biosimiliar biological product HCPCS codes

On April 1, 2018, HCPCS code Q5102 was replaced with HCPCS codes Q5103 and Q5104. For a listing of the HCPCS code changes and their code descriptors, see the table below. HCPCS Code Long Descriptor Termination Date Q5102 Injection, infliximab, biosimilar, 10 mg 03/31/2018 Q5103 Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg   Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg   ...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.